Valuation: EMV Capital plc

Market Cap 14.4M 19.13M 16.79M 15.46M 27.16M 1.82B 27.72M 186M 72.03M 893M 71.81M 70.26M 3.11B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.37M 17.76M 15.59M 14.35M 25.22M 1.69B 25.74M 173M 66.89M 829M 66.68M 65.24M 2.88B EV / Sales 2026 *
3.9x
EV / Sales 2027 * 3.9x
Free-Float
52.15%
Yield 2026 *
-
Yield 2027 * -
1 month+5.10%
6 months-9.65%
Current year-9.65%
1 week 51
Extreme 51
52
1 month 48
Extreme 48
54.75
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 51 2020-04-30
Director of Finance/CFO 45 2025-11-30
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 51 2019-10-13
Director/Board Member 47 2022-12-08
Chairman 61 2023-01-31
Date Insider Type Main position Quantity % Market Cap.
01-07Buy 7,000 0.0250%
01-07Sell 7,000 0.0250%
12-18Sell

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+11.96%-13.45% 19.11M
+0.72%+4.91%+64.77%+25.74% 3.33B
+0.95%+5.08%-13.20%+7.57% 2.91B
+0.42%+1.72%+38.60%+17.33% 1.93B
+1.72%+2.70%+85.11%+121.00% 1.22B
0.00%0.00%-1.72%-7.02% 715M
+1.39%-1.85%+170.33%+269.23% 666M
0.00%0.00%-44.78%-73.76% 405M
0.00%0.00%-4.67%-8.33% 396M
0.00%0.00%-1.83%-10.79% 372M
Average +0.52%+1.07%+30.46%+32.75% 1.2B
Weighted average by Cap. +0.75%+2.65%+37.39%+35.57%

Financials

2026 *2027 *
Net sales 3.43M 4.55M 4M 3.68M 6.47M 433M 6.6M 44.26M 17.15M 213M 17.1M 16.73M 740M 3.75M 4.98M 4.37M 4.03M 7.08M 474M 7.22M 48.43M 18.77M 233M 18.71M 18.3M 809M
Net income - -
Net Debt -1.03M -1.37M -1.2M -1.1M -1.94M -130M -1.98M -13.28M -5.15M -63.76M -5.13M -5.02M -222M 233K 309K 271K 250K 439K 29.39M 448K 3M 1.16M 14.43M 1.16M 1.14M 50.2M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., CetroMed Limited, NetScientific America, Inc., EMV Director Services Limited, EMV Capital Technology Limited, and ProAxsis Limited, among others.
Employees
21
Date Price Change Volume
26-07-01 GBX 51.50 0.00% 112
26-06-30 GBX 51.50 0.00% 2
26-06-29 GBX 51.50 0.00% 0
26-06-26 GBX 51.50 0.00% 10,274
26-06-25 GBX 51.50 0.00% 0
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5150GBP
Average target price
1.320GBP
Spread / Average Target
+156.31%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock